Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Nephrogenex Inc (NRX)

Nephrogenex Inc (NRX)
0.14 +0.01 (+7.69%) 05/10/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Tue, May 10th, 2016
Day Low
0.12
Day High
0.16
Open 0.12
Previous Close 0.13 0.13
Volume 822,900 822,900
Avg Vol 663,825 663,825
Stochastic %K 4.27% 4.27%
Weighted Alpha -91.19 -91.19
5-Day Change unch (unch) unch (unch)
52-Week Range 0.10 - 8.90 0.10 - 8.90
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,680
  • Shares Outstanding, K 12,950
  • Annual Sales, $ 0 K
  • Annual Income, $ -22,860 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.16
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.25
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/11/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.10 +40.00%
on 05/09/16
Period Open: 0.47
0.88 -84.09%
on 04/26/16
-0.33 (-70.21%)
since 04/08/16
3-Month
0.10 +40.00%
on 05/09/16
Period Open: 0.95
1.20 -88.33%
on 02/22/16
-0.81 (-85.26%)
since 02/10/16
52-Week
0.10 +40.00%
on 05/09/16
Period Open: 7.42
8.90 -98.43%
on 06/23/15
-7.28 (-98.11%)
since 05/08/15

Most Recent Stories

More News
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 54.91 (+0.75%)
TAK : 15.14 (+0.80%)
NRX.VN : 0.680 (-1.45%)
BMY : 58.90 (-0.52%)
NRX : 0.14 (+7.69%)
When Technicals and Fundamentals Converge, A Nice Uptrend Ensues

Some investors only pay attention to fundamentals. Others put more weight on technical charts. Another way of looking at it is to think of technical as being useful for quick decisions for those good at...

RIO : 62.34 (-0.84%)
NRDS : 9.32 (-0.11%)
NOA.TO : 23.02 (-5.27%)
NRX.VN : 0.680 (-1.45%)
NOA : 16.09 (-5.30%)
NRX : 0.14 (+7.69%)
24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury

An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...

TECH : 59.95 (+0.96%)
LLY : 821.67 (-0.62%)
CAPR : 11.81 (-10.36%)
NRX.VN : 0.680 (-1.45%)
NRX : 0.14 (+7.69%)
PARS : 0.0200 (-48.72%)
White Metal Partner Noronex Commences 10,000 Metre Drilling Program at the DorWit Copper-Silver Project, Namibia

THUNDER BAY, Ontario, Sept. 09, 2021 (GLOBE NEWSWIRE) -- White Metal Resources Corp. (TSXV: WHM) (FRA: CGK1) (OTCMKTS: TNMLF) (“White Metal” or the “Company”) is pleased to provide an update...

NRX.AX : 0.019 (unch)
WHM.VN : 0.060 (+9.09%)
TNMLF : 0.0408 (-0.49%)
NRX : 0.14 (+7.69%)
White Metal Partner Noronex Provides Update on Exploration Program at the DorWit Copper-Silver Project, Namibia

THUNDER BAY, Ontario, July 20, 2021 (GLOBE NEWSWIRE) -- White Metal Resources Corp. (TSXV: WHM) ( FRA: CGK1 ) ( OTCMKTS: TNMLF) (“White Metal” or the “Company”) is pleased to provide an update...

TNMLF : 0.0408 (-0.49%)
WHM.VN : 0.060 (+9.09%)
NRX : 0.14 (+7.69%)

Business Summary

NephroGenex, Inc. is a pharmaceutical company focused on the development of therapeutics to treat kidney disease. It is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients. NephroGenex, Inc. is based in United States....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.18
1st Resistance Point 0.16
Last Price 0.14
1st Support Level 0.12
2nd Support Level 0.10
3rd Support Level N/A

See More

52-Week High 8.90
Fibonacci 61.8% 5.54
Fibonacci 50% 4.50
Fibonacci 38.2% 3.46
Last Price 0.14
52-Week Low 0.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies